{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T18:10:01Z","timestamp":1756836601668,"version":"3.44.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Psoriasis, a persistent inflammatory condition with a complex origin, lacks a definitive cure despite the availability of diverse treatments. Vetpalai thailam (VT), a Siddha formulation, is commonly used for addressing various skin ailments. Analysis via GC-MS of a sample of VT oil unveiled the existence of 65 compounds. These identified phytochemical structures were then examined through molecular docking against the proinflammatory cytokines TNF-\u03b1 and IL-17A, resulting in the shortlisting of seven compounds. Among these, four displayed binding potential against TNF-\u03b1, while three exhibited similar potential against IL-17A. Further, the individual shortlisted phytochemical and protein complexes were subjected to molecular dynamics and documented their RMSDs, RMSFs, SASA, Rg, MMPBSA, and PCA profiles. Other informatics web tools were employed to predict physicochemical properties, bioactivity, drug-likeness, and toxicity scores. Three compounds identified from VT oil displayed binding potential against IL-17A, showcasing binding energies varied between \u22128.427 and \u22126.739 kcal\/mol, while four compounds exhibited potential against TNF-\u03b1, with binding energies ranging from \u22129.873 to \u22128.644 kcal\/mol. The physicochemical attributes, bioactivity, compliance with Lipinski\u2019s rule of five, and ADMET profiles of the shortlisted compounds demonstrated favorable pharmacokinetic characteristics. Consequently, this research provides valuable insights into the binding ability of phytoconstituents of VT oil against IL-17A and TNF-\u03b1, paving the way for the development of novel drugs for the treatment of psoriasis.<\/jats:p>","DOI":"10.1371\/journal.pone.0330939","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T17:28:19Z","timestamp":1756834099000},"page":"e0330939","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phytochemical and pharmacoinformatics analysis of a traditional antipsoriatic oil formulation for its potential against proinflammatory cytokines TNF-\u03b1 and IL-17A"],"prefix":"10.1371","volume":"20","author":[{"given":"Nayak Deeksha","family":"Dayanand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasudha","family":"Devi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shama Prasada","family":"Kabbekodu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6331-1047","authenticated-orcid":true,"given":"Arul","family":"Amuthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathish","family":"Pai B","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8046-7625","authenticated-orcid":true,"given":"Rajasekhar","family":"Chinta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"issue":"2","key":"pone.0330939.ref001","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"2","key":"pone.0330939.ref002","doi-asserted-by":"crossref","first-page":"20","DOI":"10.33545\/26647184.2024.v6.i2a.37","article-title":"Therapeutic targeting of TNF-\u03b1 and IL-17 in psoriasis: mechanisms of action and clinical efficacy of biologic agents","volume":"6","author":"P Riya","year":"2024","journal-title":"Int J Pharm Pharm Res"},{"key":"pone.0330939.ref003","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2147\/CCID.S420850","article-title":"Cellular mechanisms of psoriasis pathogenesis: a systemic review","volume":"16","author":"M Wu","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"pone.0330939.ref004","doi-asserted-by":"crossref","first-page":"1015182","DOI":"10.3389\/fimmu.2022.1015182","article-title":"IL-17A and TNF-\u03b1 inhibitors induce multiple molecular changes in psoriasis","volume":"13","author":"Q Dong","year":"2022","journal-title":"Front Immunol"},{"key":"pone.0330939.ref005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3410\/M1-30","article-title":"The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities","volume":"1","author":"J Yost","year":"2009","journal-title":"F1000 Med Rep"},{"issue":"21","key":"pone.0330939.ref006","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa030409","article-title":"Etanercept as monotherapy in patients with psoriasis","volume":"349","author":"CL Leonardi","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0330939.ref007","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jaad.2004.02.021","article-title":"Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial","volume":"51","author":"AB Gottlieb","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"pone.0330939.ref008","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jaad.2006.05.027","article-title":"Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study","volume":"55","author":"KB Gordon","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"pone.0330939.ref009","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis--results of two phase 3 trials","volume":"371","author":"RG Langley","year":"2014","journal-title":"N Engl J Med"},{"issue":"9","key":"pone.0330939.ref010","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0025-6196(11)62116-2","article-title":"Topical therapies for localized psoriasis","volume":"76","author":"PM Witman","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"pone.0330939.ref011","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2147\/CCID.S380218","article-title":"The anti-psoriatic efficacy and safety profile of topical and intralesional methotrexate: a literature review","volume":"15","author":"C Chaiyabutr","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"5","key":"pone.0330939.ref012","first-page":"558","article-title":"Psoriasis: update on topical therapy from the American Academy of Dermatology","volume":"105","author":"AM Shreiber","year":"2022","journal-title":"Am Fam Physician"},{"issue":"17","key":"pone.0330939.ref013","doi-asserted-by":"crossref","first-page":"13313","DOI":"10.3390\/ijms241713313","article-title":"Challenges and future trends in the treatment of psoriasis","volume":"24","author":"H-J Lee","year":"2023","journal-title":"Int J Mol Sci"},{"key":"pone.0330939.ref014","doi-asserted-by":"crossref","first-page":"980419","DOI":"10.1155\/2013\/980419","article-title":"Promising new treatments for psoriasis","volume":"2013","author":"S Dubois Declercq","year":"2013","journal-title":"Sci World J"},{"issue":"4","key":"pone.0330939.ref015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S2221-1691(12)60021-5","article-title":"Screening of flavonoid \u201cquercetin\u201d from the rhizome of Smilax china Linn. for anti-psoriatic activity","volume":"2","author":"A Vijayalakshmi","year":"2012","journal-title":"Asian Pac J Trop Biomed"},{"issue":"1","key":"pone.0330939.ref016","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clindermatol.2007.11.010","article-title":"Siddha medicine--background and principles and the application for skin diseases","volume":"26","author":"JJ Thas","year":"2008","journal-title":"Clin Dermatol"},{"issue":"1","key":"pone.0330939.ref017","first-page":"58","article-title":"Clinical study of Vetapalai (Wrightia tinctoria) oil in the treatment of Kalanjagapadai (psoriasis)","volume":"2","author":"JR Krishnamurthi","year":"1981","journal-title":"J Res Ayur Siddha"},{"key":"pone.0330939.ref018","first-page":"223","volume-title":"Siddha Maruthuvam Chirappu","author":"R Thiyagarajan","year":"1995"},{"issue":"4","key":"pone.0330939.ref019","first-page":"2434","article-title":"Anti-inflammatory study of Wrightia tinctoria R.Br stem bark in experimental animal models","volume":"2","author":"PR Tharkar","year":"2010","journal-title":"Int J PharmTech Res"},{"issue":"3","key":"pone.0330939.ref020","first-page":"141","article-title":"Anti-inflammatory, analgesic, and antipyretic activities of 777 oil\u2014a Siddha medicine","volume":"6","author":"D Ghosh","year":"1985","journal-title":"Bull Med Ethnobot Res"},{"key":"pone.0330939.ref021","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.52711\/0974-360X.2021.01149","article-title":"Long-term toxicity study of a Siddha formulation Vetpalai thailam (VT) in rats","author":"G Shenoy","year":"2021","journal-title":"RJPT"},{"issue":"2","key":"pone.0330939.ref022","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"O Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"3","key":"pone.0330939.ref023","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/07391102.2020.1719200","article-title":"Molecular docking and molecular dynamics simulation approach to screen natural compounds for inhibition of Xanthomonas oryzae pv. Oryzae by targeting peptide deformylase","volume":"39","author":"T Joshi","year":"2021","journal-title":"J Biomol Struct Dyn"},{"issue":"4","key":"pone.0330939.ref024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003318","article-title":"Use of long term molecular dynamics simulation in predicting cancer associated SNPs","volume":"10","author":"A Kumar","year":"2014","journal-title":"PLoS Comput Biol"},{"issue":"30","key":"pone.0330939.ref025","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1021\/acs.biochem.8b00441","article-title":"Complete coupled binding-folding pathway of the intrinsically disordered transcription factor protein Brinker revealed by molecular dynamics simulations and markov state modeling","volume":"57","author":"AP Collins","year":"2018","journal-title":"Biochemistry"},{"key":"pone.0330939.ref026","doi-asserted-by":"crossref","first-page":"1003816","DOI":"10.3389\/fchem.2022.1003816","article-title":"Combined 3D-QSAR, molecular docking and dynamics simulations studies to model and design TTK inhibitors","volume":"10","author":"N Ashraf","year":"2022","journal-title":"Front Chem"},{"issue":"16","key":"pone.0330939.ref027","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","article-title":"Structure-based virtual screening for drug discovery: principles, applications and recent advances","volume":"14","author":"E Lionta","year":"2014","journal-title":"Curr Top Med Chem"},{"key":"pone.0330939.ref028","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.3762\/bjoc.12.267","article-title":"Computational methods in drug discovery","volume":"12","author":"SP Leelananda","year":"2016","journal-title":"Beilstein J Org Chem"},{"issue":"13","key":"pone.0330939.ref029","first-page":"186","article-title":"A comprehensive review on: a plant Cassia tora (Fabaceae) as an antipsoriatic agent","volume":"9","author":"KA Sudhakar","year":"2020","journal-title":"World J Pharm Res"},{"key":"pone.0330939.ref030","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.3389\/fimmu.2019.03096","article-title":"IL-17A in psoriasis and beyond: cardiovascular and metabolic implications","volume":"10","author":"E von Stebut","year":"2020","journal-title":"Front Immunol"},{"issue":"4","key":"pone.0330939.ref031","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1084\/jem.176.4.1053","article-title":"Myristyl acylation of the tumor necrosis factor alpha precursor on specific lysine residues","volume":"176","author":"FT Stevenson","year":"1992","journal-title":"J Exp Med"},{"issue":"14","key":"pone.0330939.ref032","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.3390\/ijms21144952","article-title":"From inflammation to cutaneous repair: topical application of lupeol improves skin wound healing in rats by modulating the cytokine levels, NF-\u03baB, Ki-67, growth factor expression, and distribution of collagen fibers","volume":"21","author":"F Pereira Beserra","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"pone.0330939.ref033","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/107999004322813336","article-title":"Panax ginseng induces production of proinflammatory cytokines via toll-like receptor","volume":"24","author":"T-A Nakaya","year":"2004","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"pone.0330939.ref034","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jep.2011.04.048","article-title":"Panax ginseng ameliorates airway inflammation in an ovalbumin-sensitized mouse allergic asthma model","volume":"136","author":"DY Kim","year":"2011","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"pone.0330939.ref035","first-page":"62","article-title":"Lipid profiling by GC-MS and anti-inflammatory activities of Ceiba pentandra seed oil","volume":"4","author":"Ch Ravi Kiran","year":"2014","journal-title":"J Biol Active Prod Nat"},{"issue":"14","key":"pone.0330939.ref036","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1021\/acs.jafc.0c01414","article-title":"A Combination of formic acid and monolaurin attenuates Enterotoxigenic Escherichia coli induced intestinal inflammation in piglets by inhibiting the NF-\u03baB\/MAPK pathways with modulation of gut microbiota","volume":"68","author":"C Ren","year":"2020","journal-title":"J Agric Food Chem"},{"issue":"4","key":"pone.0330939.ref037","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.jksus.2020.03.003","article-title":"Kinetics modelling of acid hydrolysis of cassava (Manihot esculanta Cranz) peel and its hydrolysate chemical characterisation","volume":"32","author":"EO Ajala","year":"2020","journal-title":"J King Saud Univ Sci"},{"key":"pone.0330939.ref038","doi-asserted-by":"crossref","first-page":"30859","DOI":"10.1038\/srep30859","article-title":"Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists","volume":"6","author":"S Liu","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0330939.ref039","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1039\/C7MD00464H","article-title":"Artificial macrocycles as IL-17A\/IL-17RA antagonists","volume":"9","author":"W Wang","year":"2018","journal-title":"Medchemcomm"},{"issue":"3","key":"pone.0330939.ref040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/cryst9030177","article-title":"Fab fragment of VHH-based antibody netakimab: crystal structure and modeling interaction with cytokine IL-17A","volume":"9","author":"O Kostareva","year":"2019","journal-title":"Crystals"},{"issue":"1","key":"pone.0330939.ref041","doi-asserted-by":"crossref","first-page":"22","DOI":"10.46439\/toxicology.5.021","article-title":"Identification of novel bioactivities from bee venom to target TNF-\u03b1 for cancer therapy","volume":"5","author":"D Saravanan","year":"2023","journal-title":"Arch Clin Toxicol"},{"issue":"1","key":"pone.0330939.ref042","doi-asserted-by":"crossref","first-page":"20974","DOI":"10.1038\/s41598-020-77750-3","article-title":"Identification of potential TNF-\u03b1 inhibitors: from in silico to in vitro studies","volume":"10","author":"K Zia","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"pone.0330939.ref043","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/biom11020329","article-title":"Structure-based virtual screening of tumor necrosis factor-\u03b1 inhibitors by cheminformatics approaches and bio-molecular simulation","volume":"11","author":"SA Halim","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"pone.0330939.ref044","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s11030-024-10900-1","article-title":"In silico and in vitro studies for the identification of small molecular inhibitors from Euphorbia hirta Linn for rheumatoid arthritis: targeting TNF-\u03b1-mediated inflammation","volume":"29","author":"Y Velmurugan","year":"2025","journal-title":"Mol Divers"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0330939","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T17:28:26Z","timestamp":1756834106000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0330939"}},"subtitle":[],"editor":[{"given":"Yusuf Oloruntoyin","family":"Ayipo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":44,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0330939","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]}}}